Merrimack Pharmaceuticals Inc (MACK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MACK | CCCC | ALEC | ||
| Company | Merrimack Pharmaceuticals Inc | C4 Therapeutics Inc | Alector Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 15.15 | 2.41 | 2.03 | ||
| High | 15.17 | 2.66 | 2.19 | ||
| Low | 15.13 | 2.41 | 2.03 | ||
| Latest | 15.13 | 2.63 | 2.15 | ||
| Change | unch | +0.28 | +0.13 | ||
| % Change | unch | +11.91% | +6.44% | ||
| Volume | 1,255,700 | 2,060,900 | 352,500 | ||
| 20-Day Average Volume | 396,880 | 2,398,360 | 715,000 | ||
| Previous Close | 15.13 | 2.35 | 2.02 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 14.95 | 2.78 | 2.13 | ||
| 20-Day Raw Stochastic | 92.47% | 21.71% | 34.21% | ||
| 20-Day Relative Strength | 74.45 | 51.62 | 52.98 | ||
| Weighted Alpha | +23.43 | +43.83 | +123.77 | ||
| Today's Opinion | 100% Buy | 64% Buy | 88% Buy | ||
| Previous Opinion | 100% Buy | 16% Buy | 40% Buy | ||
| Last Month's Opinion | 80% Buy | 24% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.07% since 05/10/24 | +5.20% since 03/24/26 | +3.37% since 03/24/26 | ||
| Low | 15.10 on 05/13/24 | 2.30 on 03/30/26 | 1.95 on 03/30/26 | ||
| High | 15.16 on 05/17/24 | 2.80 on 03/26/26 | 2.22 on 03/25/26 | ||
| 1-Month | |||||
| %Chg | +3.07% since 04/17/24 | -2.59% since 02/27/26 | -11.52% since 02/27/26 | ||
| Low | 14.67 on 04/18/24 | 2.30 on 03/30/26 | 1.89 on 03/06/26 | ||
| High | 15.16 on 05/17/24 | 3.82 on 03/09/26 | 2.65 on 03/10/26 | ||
| 3-Month | |||||
| %Chg | +2.93% since 02/16/24 | +24.06% since 12/26/25 | +48.28% since 12/26/25 | ||
| Low | 14.60 on 03/12/24 | 1.69 on 02/05/26 | 1.44 on 12/29/25 | ||
| High | 15.16 on 05/17/24 | 3.82 on 03/09/26 | 2.65 on 03/10/26 | ||
| 6-Month | |||||
| %Chg | +18.02% since 11/17/23 | +17.94% since 09/26/25 | -30.65% since 09/26/25 | ||
| Low | 12.54 on 11/30/23 | 1.69 on 02/05/26 | 1.09 on 12/03/25 | ||
| High | 15.89 on 02/13/24 | 3.82 on 03/09/26 | 3.40 on 10/16/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 223,742 | 229,308 | 222,933 | ||
| Shares Outstanding, K | 14,788 | 97,578 | 110,363 | ||
| Annual Sales | 0 | 35,950,000 | 21,050,000 | ||
| Annual Net Income | -1,180,000 | -104,990,000 | -142,930,000 | ||
| Last Quarter Sales | 0 | 11,020,000 | 6,240,000 | ||
| Last Quarter Net Income | -240,000 | -20,490,000 | -37,270,000 | ||
| 60-Month Beta | 1.45 | 2.85 | 0.57 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.03 on 05/15/24 | -0.18 on 02/26/26 | -0.34 on 02/25/26 | ||
| Latest Earnings Date | 08/01/24 | 05/06/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | 05/30/17 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||